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studied 100 hypertensive patients, without a history of prior myocerdial in-
farction, matched for age, race, and gender. The QT interval was measured
from the onset of the QRS complex to the end of the T wave in each lead
of a standard 12-lead ECG. QT dispersion wee calculated as the difference
between the longest and shortest QT intervals (QT max-min). LV mass was
measured by 2-D guided M-mode echocardiogrephy. LVHwas defined as LV
mass index ? 134 gtim2 in men and ? 110 grnJm2in women. Fifty patients
had echocardiographically documented LVH and 50 had normal LV mass
index. The ECG measurements were made by an investigator blindad to the
echocardiographic results.
Patients with and without LVH were similar in age (55 + 14 vs. 53+ 12
yeare, p = NS), race (88% African American, 34% Caucasian), and gender
(58% female). The mean LV mass index was 169 + 54 gtim2 in patients
with LVH and 95 + 19 grnlmz in those with normal LV mass (p <0.001
for difference). Patients with LVH had a greater mean QT max-min (70
+ 27 msec) than hypertensive without LVH (46 + 27 msec, p <0.001
for difference). The association between LVH and increased QT dispersion
remained significant when men, women, African Americans, and Caucasians
were examined separately.
We conclude that LVH due to hypertension is eeeociated with increased
QT dispersion. These findings suggest a possible role for depolarization
inhomogeneity in the enhanced risk of sudden cardiac death in patients with
hypertensive LVH.
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Hypertensive left ventricular hypertrophy (LVH) is associated with increased
rick of arrhythmias and mortality. However, no clinical study demonstrated a
significant relation between ventricular arrhythmias or other arrhythmogenic
markers and mortality in systemic hypertension.
To evaluate the prognostic value of arrhythmogenic markers in systemic
hypertension, we included between 1967and 1993214 hypertensivepatients
(pts), 127 men and 67 women, 59.1 + 12.6 yeare old, without symptomatic
coronary disease, myocerdial infarction, systolic dysfunction, electrolyte dis-
turbance or antiarrf?ythmic therapy. At inclusion, an ECG, a 24 h Helter
ECG (204 pts) with Lown classification of ventricular arrhythmias, an echo-
cardiography (reliable in 167 pts) with left ventricular mass index and ejection
fraction calculation, a SAECG (125 pts, enrolled after 1986) with ventricu-
lar late potentials (LP) were recorded. QT interval dispersion (QTd) was
calculated on 12 leads standard ECG and LVH was appreciated.
At baseline echocerdiographic LVH was recorded in 63 pts (33.7%) with
normal ejection fraction (75 + 7.4?4.).Advanced Lown classes were found
in 71 pte (34.8%), and LP in 27 pts (21.6%). After a mean followup of 42.4
+ 26.8 months, all-cause mortality was 11.2% (24 pts); 17 pts died of cer-
diac causes (7’.9%);of these 9 patients (4.2%) died suddenly. In univariate
analysis, age, strain pattern of LVH, advanced Lown classes and abnormal
QT dispersion (> 80 msec) were significantly related to global, cardiac and
sudden death (p s 0.01). Left ventricular mass index was closely related
to cardiac mortality (p = 0.002). LP failed to predict mortality. In multivan-
ate analysis, age was an independent predictor of global mortality, cardiac
and sudden death. Advanced Lown classes was an independent predictor
of global mortalily, increasing the risk of death 2.9 fold [1.2-.6] (Cl 95%).
Abnormal QT dispersion was an independent predictor of cardiac death, in-
creasing the risk of cardiac death 3.2 fold [1.1-9.6] (Cl 95%). The association
of abnormal QT dispersion and advanced Lown classea was an independent
predictor of global and’cerdiac moilality, increasing the risk of death 2.9 fold
[1.3-6.6] and the risk of cardiac death 3.1 fold [1.1-8.8] (Cl 95%).
Thus, in hypertensive pts an abnormal QT dispersion and an advanced
Lown class, but not LP,have a prognostic value.
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Antihypartensive drugs are known to reduce ventricular hypertrophy. To in-
vestigate the process of ventricular remodeling during the course of such
a reduction, we studied 25 patients with untreated essential hypertension.
Patients received 25 mg ceptopril twice a day for24 months. Cardiovascular
and hemodynamic findings were assessed by echocardiography at baseline
and after 6, 12, 18 and 24 months. Blood pressure was reduced from 165 +
17/102 + 5 mm Hgto 127 + 14/69 +7 mm Hg (p < 0.001) after 6months and
remained at those levels thereafter. Left ventricular mass index was reduced
6%, 24%, 34%, and 41%, and interventricular septal thickness and posterior
wall thickness were both reduced 6%, 17%,25%, and 25% at6, 12, 18and 24
months, respectively (p = NS, <0.01, e 0.001, and c 0.001, respectively).
Left ventricular cavity area increased 15%, 26%, 39%, and 42%, and left
ventricular wall area diminished 9?!.,15Y0,24%, and 30% at 6, 12, 16, and 24
months, respectively (p <0.01, <0.01, <0.001, and <0.001, respectively).
Normalization of left ventricular mass index in all patients required 24 months
of therapy.
These findings indicate that: 1) there is increase in cavity area which
normalized wall stress preceding the reduction in left ventricular mass, 2)
there is a delay for significant reduction in left ventricular mass index until
after 18 months of therapy, and 3) there is progressive increase in cardiac
index and reduction in total peripheral resistance even after 24 months of
antihypertensive treatment.
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In previous studies, we demonstrated that in ANG1l-treated rats, prevention
of cardiac hypertrophy (CH) by enalapril was blunted by bradykinin (BK)
blockade by Hoe140. The putative role of BK was assessed by chronic
exogenous BK infusion and endogenous BK blockade in 54 male Sprague-
Dawley rats infused with ANGIL ANGII (200 ng/kg/min) alone and associated
with BK at low (BKa, 15 n@kg/day) and high doses (BKb, 100 ng/k@day)
or with Hoe140 (Hoe, 300 #g/k@day) were delivered by Alzet pumps for
10 days and compared to control animals (Veh). Valuee of mean arterial
pressure (MAP,mmHg) and cardiac output (CO, ml/min/kg bw, microsphere
technique) in conscious rats, and heart weight (HW, mglg bw) at the end
of the, study are reported below. Results were submitted to ANOVA and
expressed as M + SEM.
Veh ANGII BKa BKb Hoe
MAP 111*2 133+3* 130+5* 140* 10” 137l 6*.
co 399*37 233+ 30’ 302+ 36* 3s3* s# 276+ 9*
HVJ 2.S9+0.05 3.56+ 0.10’ 3.59* 0.14” 3.59+ 0.11” 3.55+ 0.17”
“indicstesp <0.05 vs Veh; ‘p <0.05 vs ANGII.
Thus, BK-receptor blockade did not influence the development of HTA
and CH, High-dose BK increased CO mainly through an increaee in stroke
volume but did not affect final MAP and CH. In conclusion, in the absence
of ACEI, BK do not seem to affect arterial pressure and CH in ANG1l-treatad
rats.
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Thelongterm (> 3 years) evolution of Ieftventricular filling was assessed with
pulsed Doppler recording of mitral flow in 73 never treated hypertensives. At
entry we measured office BP, left ventricular mass (LVM, 2D guided M mode
echo, Devereux’s formula, indexed for height) and mitral flow (at the level
of mitral annulus, measurement of peak velocities of earfy (E) and late (A)
flows). At least 5 cycles of echo and Doppler were recorded on a strip chart
recorder (100 mrnk). Fourteen pte (10 males, aged 47 + 11yeare, group 1)
with borderline hypertension were left untreated, the others (46 males, aged
52 + 10 yeare, group 2) received various non randomised drugs, mainly
beta-blockers, during the whole follow-up. At the final visit (mean= 61 + 13
months later) another echo-Doppler was performed in the same conditions.
All tracings were coded and read blindly. ANOVA was performed with HR
(measured on tracings) as a covariate for Doppler. In the whole population
age (r= –0.40, p c 0.0001) and HR (r= –0.38, p < 0.0001) were correlated
to E/A, not BP and LVM/h. In group 1, BP (153+ 22/94+ 14 Vs 154 + 15/98
+ IOmmHg) and LVM/h (131 + 39VS 126 +34 g/m) remained unchanged, E
decreased (53 + 15 Vs 58 + 12 crnls, p < 0.05) with a trend to WA decrease
(0.94 + 0.34 Vs 1.04 + 0.34, p = 0.06). In group 2, despite a significant
reduction in BP (146 + 1W90+ 9 Vs 188 + 16/103+8 mmHg, p < 0.0001),
in LVM/h (141 + 38 Vs 158 +38 g/m, p < 0.001) and HR (64 + 10 Vs 72 +
10 bf/min) we observed a significant decrease in E/A (0.67 + 0.27 Vs 0.92
+ 0.29, p < 0.01). Conclusion.’Peak velocity of early filling and E/A ratio
decrease with age in hypertensives, treatment appears unable to slow this
process despite BP lowering and LVH regression.
